Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1996-12-20
pubmed:abstractText
The purpose of the study is to compare the clinical efficacy and safety of ciprofloxacin ophthalmic solution 0.3% (Ciloxan) with a standard therapy regimen (fortified tobramycin, 1.3%-cefazolin, 5.0%) for treating bacterial corneal ulcers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0161-6420
pubmed:author
pubmed:issnType
Print
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1854-62; discussion 1862-3
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8942881-Adolescent, pubmed-meshheading:8942881-Adult, pubmed-meshheading:8942881-Aged, pubmed-meshheading:8942881-Aged, 80 and over, pubmed-meshheading:8942881-Anti-Bacterial Agents, pubmed-meshheading:8942881-Anti-Infective Agents, pubmed-meshheading:8942881-Bacteria, pubmed-meshheading:8942881-Cefazolin, pubmed-meshheading:8942881-Cephalosporins, pubmed-meshheading:8942881-Child, pubmed-meshheading:8942881-Ciprofloxacin, pubmed-meshheading:8942881-Cornea, pubmed-meshheading:8942881-Corneal Ulcer, pubmed-meshheading:8942881-Double-Blind Method, pubmed-meshheading:8942881-Drug Therapy, Combination, pubmed-meshheading:8942881-Eye Infections, Bacterial, pubmed-meshheading:8942881-Female, pubmed-meshheading:8942881-Humans, pubmed-meshheading:8942881-Male, pubmed-meshheading:8942881-Middle Aged, pubmed-meshheading:8942881-Ophthalmic Solutions, pubmed-meshheading:8942881-Prospective Studies, pubmed-meshheading:8942881-Tobramycin
pubmed:year
1996
pubmed:articleTitle
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
pubmed:affiliation
Medical College of Wisconsin, Milwaukee, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study